This HTML5 document contains 64 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64717121
rdf:type
wikibase:Item
schema:description
clinical trial klinisch onderzoek клінічне випробування ensayu clínicu
rdfs:label
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
skos:prefLabel
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
schema:name
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
p:P1476
wds:Q64717121-24620A37-26A0-4CA2-B5CC-8FCF0F4145D4
wdt:P1476
A Phase II Evaluation of Combination Bevacizumab (NCI-Supplied Agent: NSC #70486) and Temsirolimus (CCI-779, NCI-Supplied Agent, NSC #683864) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
p:P582
wds:Q64717121-7547921B-009F-4A36-BB1F-11BA6B47B6B5
wdt:P582
2011-07-15T00:00:00Z
p:P31
wds:Q64717121-A4B1711C-399D-43A8-9FFC-AB26050F1997
wdt:P31
wd:Q30612
p:P580
wds:Q64717121-700A30EF-4FA9-4F64-8A85-8373BEEA2B3A
wdt:P580
2008-09-01T00:00:00Z
p:P17
wds:Q64717121-4945D281-616B-4127-A790-E6D475949073
wdt:P17
wd:Q30
p:P6153
wds:Q64717121-02B4EEAF-C8AB-4E1C-9F9D-9D8F75D83957 wds:Q64717121-07663093-1194-48C3-8040-C05E1E690D80 wds:Q64717121-0F5E38C0-EF52-4D45-A773-35C4D5F06F26 wds:Q64717121-9C34118A-AF67-4381-9AA3-B425F7403BA4 wds:Q64717121-A2562320-0865-4C0F-9708-EB97364A7046 wds:Q64717121-6D842CDD-0E1C-434A-8631-CE1754CA2D06 wds:Q64717121-35411255-8B3C-4BA9-9DF5-265BCC999B00 wds:Q64717121-360C8827-A87A-4577-AB04-77B9297E280F wds:Q64717121-FBFC0B3E-3D08-4C16-B81A-C05CE5F95EA9 wds:Q64717121-DF60F495-2822-42B5-8E80-60C079AD6C5D wds:Q64717121-E0534A12-B9C9-4FCC-B1B9-C43BCD9DAFC1 wds:Q64717121-E232AD63-6A78-4CFE-97D6-6E9100B11770 wds:Q64717121-A6012843-2188-4C41-A607-E9DBDBE059CF wds:Q64717121-BA08A593-CA2D-41E1-B957-F295D96C0361
wdt:P6153
wd:Q1808012 wd:Q734774 wd:Q7972509 wd:Q1535116 wd:Q131252 wd:Q30254005 wd:Q5476635 wd:Q7896014 wd:Q7847720 wd:Q17514683 wd:Q7971940 wd:Q7895818 wd:Q87932226 wd:Q392667
p:P4844
wds:Q64717121-5E7C6CE4-9FC0-4D87-98FC-A223185AB3D0 wds:Q64717121-6A8ADE33-8F1C-4E6C-9E53-B51A52AAECA6 wds:Q64717121-C8382C5B-0A71-4E00-BB1F-80D5139D5F7E
wdt:P4844
wd:Q413299 wd:Q50429626 wd:Q32089
p:P2899
wds:Q64717121-58FE4C6B-D31E-47A5-9A4F-AAE7AD7ACD7F
wdt:P2899
18
p:P1050
wds:Q64717121-8AA01C83-5375-4A7D-B8BC-8E98C5CB60FB
wdt:P1050
wd:Q33525
p:P1132
wds:Q64717121-926E3E54-222C-4271-AA9F-ABDC0F1FC0EC
wdt:P1132
53
p:P8363
wds:Q64717121-8387921B-1C89-49EF-8727-E508D3E07E4F
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64717121-EDBCDEDC-7B2C-41CC-93A3-185B0B767F43
wdt:P3098
NCT00723255
p:P6099
wds:Q64717121-24325A77-14AC-4F79-A2D6-6B089924D200
wdt:P6099
wd:Q42824440